In conclusion, this first study of flavocoxid in DMD boys showed that it was well tolerated and able to induce a reduction in the serum biomarkers of inflammation response and oxidative stress, most likely through a pivotal NF-κB inhibition. Here, NFKB1 is linked to Duchenne muscular dystrophy.